Pharmacoeconomic rationale for switching patients with rheumatic diseases from original biologic disease-modifying antirheumatic drugs to biosimilars in context of the Russian healthcare system
Objective: to analyze the pharmacoeconomic efficiency of biosimilars in context of national healthcare system.Material and methods. Based on the developed interactive pharmacoeconomic model, we made an analysis of the impact on the budget of treatment with biologic disease-modifying antirheumatic dr...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Russo |
| 出版事項: |
IMA-PRESS LLC
2022-06-01
|
| シリーズ: | Современная ревматология |
| 主題: | |
| オンライン･アクセス: | https://mrj.ima-press.net/mrj/article/view/1309 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|